# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-23-000027
Filing Date
2023-05-08
Accepted
2023-05-08 16:07:29
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20230331.htm iXBRL | 10-Q | 1240578
2 | EX-10.2 | a102-directorcompensationa.htm | EX-10.2 | 29740
3 | EX-10.3 | a103-changeinctrlseverance.htm | EX-10.3 | 123810
4 | EX-31.1 | lgnd_33123exhibit311.htm | EX-31.1 | 15258
5 | EX-31.2 | lgnd_33123exhibit312.htm | EX-31.2 | 15528
6 | EX-32.1 | lgnd_33123exhibit321.htm | EX-32.1 | 11256
12 |  | lgnd-20230331_g1.jpg | GRAPHIC | 51754
| Complete submission text file | 0000886163-23-000027.txt |  | 7157068

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20230331.xsd | EX-101.SCH | 43927
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20230331_cal.xml | EX-101.CAL | 88955
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20230331_def.xml | EX-101.DEF | 243643
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20230331_lab.xml | EX-101.LAB | 624482
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20230331_pre.xml | EX-101.PRE | 384146
56 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20230331_htm.xml | XML | 1175094

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 23897765
SIC: 2834 Pharmaceutical Preparations